Business Wire

Oscilloquartz delivers assured timing for mission-critical harsh environments with ruggedSync™ Series OSA 5510

1.6.2026 14:00:00 CEST | Business Wire | Press release

Share

News summary: Defense operations require resilient timing architectures that maintain synchronization in contested and GNSS-denied environments ruggedSync™ Series OSA 5510 delivers assured timing and extended holdover in a MIL-qualified platform for tactical, deployable operations Zero-trust resiliency with diversified cPNT sources, including M-Code, PRS and STL, strengthens operational continuity for defense communications, navigation and mission-critical infrastructure

Oscilloquartz today launched its ruggedSync™ Series OSA 5510, a ruggedized timing and synchronization platform engineered for defense and other harsh, mission-critical environments. Designed for deployment in tactical communications networks, mobile command centers (MCCs), aviation systems and other highly demanding operational environments, the OSA 5510 combines PTP grandmaster and NTP server functionality with synchronization assurance and resilient holdover in a compact MIL-qualified platform. Multi-band GNSS support, encrypted and authenticated timing options and environmental protection enable operation in contested and GNSS-denied environments where trusted synchronization must be maintained.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260601763766/en/

Oscilloquartz’s ruggedSync™ Series OSA 5510 delivers resilient, high-precision timing for mission-critical defense networks.

“Our new ruggedSync Series OSA 5510 extends the Oscilloquartz assured PNT portfolio into tactical and deployable defense environments,” said Gil Biran, GM of Oscilloquartz. “Combined with our optical cesium clocks, synchronization assurance technologies, PTP grandmasters and synchronization management solutions, it reinforces Oscilloquartz’s ability to deliver the industry’s most comprehensive timing portfolio. This enables us to support truly end-to-end, multi-layered timing architectures designed to maintain trusted synchronization and resilient PNT capabilities across highly demanding and contested environments.”

Built to support resilient defense timing architectures, the OSA 5510 integrates advanced synchronization technologies and flexible mission-critical interfaces within a hardened platform compliant with MIL-STD-810H and MIL-STD-461G. The solution supports IEEE 1588v2 PTP, SyncE and secure NTP services, while programmable I/O and timecode interfaces, including STANAG, Have Quick, IRIG and PPS/CLK distribution, support diverse defense payloads and operational requirements. Optical and copper SFP/SFP+ 1G/10G interfaces and dual power feeds further enable deployment across modern high-bandwidth defense networks.

The ruggedSync Series OSA 5510 strengthens multi-source resilience through zero-trust architecture, with support for M-Code, Galileo PRS and Iridium STL. Extended holdover, low phase-noise outputs, and jamming and spoofing detection and mitigation help maintain continuity during GNSS degradation or disruption, while White Rabbit readiness supports advanced timing distribution use cases. The launch also builds on Oscilloquartz’s expanding global aerospace, defense and government partnerships, including regional representative and VAR relationships supporting resilient timing and assured PNT deployments across the Americas, EMEA and Asia-Pacific.

“Modern defense operations require synchronization technologies that are resilient, flexible and straightforward to integrate across diverse mission environments,” commented Igal Pinhasov, VP of product line management at Oscilloquartz. “Our OSA 5510 builds on the same core timing and synchronization technologies deployed across the broader Oscilloquartz portfolio, helping to deliver a more consistent operational experience across network layers and deployment models. By leveraging common capabilities and synchronization management approaches, organizations can simplify integration and more easily scale resilient timing infrastructures across evolving defense networks.”

About Oscilloquartz

Oscilloquartz, an Adtran company, delivers high-precision timing and synchronization solutions for mobile networks and critical infrastructure, enabling assured positioning, navigation and timing (aPNT) with multi-source resilience and long holdover. With over 75 years of expertise, Oscilloquartz combines innovation with proven reliability to strengthen network resilience in a GNSS-challenged world. Our portfolio includes optically pumped atomic cesium clocks, PTP grandmasters, GNSS receivers and advanced synchronization management tools for in-service assurance. These solutions maintain accuracy and availability even under jamming or spoofing attacks, supporting communications, power, aviation, transport, defense, finance and broadcast networks. For more information, please visit www.oscilloquartz.com.

Published by
Oscilloquartz
www.oscilloquartz.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20260601763766/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

AIM Expands Life Sciences Supply Chain Capabilities and Hires New Partner, Thomas Ebel1.6.2026 15:01:00 CEST | Press release

AIM today announced the appointment of veteran pharma supply chain expert Thomas Ebel as Partner, effective June 15. Mr. Ebel brings more than 25 years of supply chain consulting experience at leading firms including CAMELOT, McKinsey, and Accenture, and will anchor a broader initiative to expand AIM’s end-to-end supply chain capabilities. According to Richard de Bakker, Statutory Director and Founder at AIM, the firm is significantly expanding its capabilities around “end-to-end” supply chain needs. “AIM is well known as a leader in supply chain development for launch, as well as optimization of existing supply chains — supporting clients in getting their finished products to patients,” said Mr. de Bakker. “We are now adding new capabilities in supply chain diagnostics and strategy, end-to-end planning optimization, supply reliability, and working capital optimization, among others. Combined with AIM’s established supply chain expertise, this expanded offering gives clients true ‘end-

Seoul Semiconductor's World-First 'HV Opto-Semiconductor' Powers Up Global Top 4 Automakers1.6.2026 15:00:00 CEST | Press release

Seoul Semiconductor Co., Ltd. (KOSDAQ: 046890), a global opto-semiconductor technology company, announced that its world's first High Voltage (HV) opto-semiconductor technology has entered mass production with four of the world's top automotive brands across the Americas, Europe, and Asia, with plans to expand supply to 10 models by the end of the year. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260601232986/en/ Comparison: Conventional 3V LED vs. Seoul Semiconductor 12V 'HV Opto-Semiconductor' (Figure: Seoul Semiconductor) The technology combines micro-scaled opto-semiconductor chips capable of 12V single-chip operation — as opposed to conventional 3V LEDs — with a high-voltage (HV) driver technology. This enables a reduction of more than 10% in the number of driver-related components used in hybrid and electric vehicles, while lowering power consumption by approximately 10%, contributing to cost reduction and simplific

Vertex Announces US FDA Acceptance of Biologics License Application for Accelerated Approval of Povetacicept in IgA Nephropathy1.6.2026 14:00:00 CEST | Press release

- FDA assigns Prescription Drug User Fee Act (PDUFA) target action date of November 30, 2026 – Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) has accepted its Biologics License Application (BLA) submission for povetacicept, an investigational engineered fusion protein and dual inhibitor of the BAFF (B cell activating factor) and APRIL (a proliferation inducing ligand) cytokines, in adults with immunoglobulin A nephropathy (IgAN). The FDA has assigned a Prescription Drug User Fee Act (PDUFA) target action date of November 30, 2026. If approved, povetacicept will become the first commercialized therapy in Vertex’s emerging nephrology franchise. “The Phase 3 RAINIER trial is the largest conducted in IgAN and achieved full enrollment faster than any contemporary IgAN trial, reflecting the significant unmet need in IgAN and our urgency to bring povetacicept to patients with this serious disease,” said Nia Tatsis, Ph.D., Executi

Winston Taylor Completes Historic Transatlantic Combination1.6.2026 13:01:00 CEST | Press release

Transatlantic powerhouse law firm established for the businesses, people, and markets driving capital and innovation Winston Taylor announces today that Winston & Strawn and Taylor Wessing’s U.K.-led business have officially launched as a single combined firm, creating a premier transatlantic law firm built for the needs of the businesses, people, and markets driving capital and innovation. One of the largest transatlantic firms, with more than 1,400 lawyers spanning the United States, the United Kingdom, Europe, Latin America, and the Middle East, Winston Taylor is built to meet clients’ evolving global needs for counsel. “As Winston Taylor, we are centered on a client-first approach and will be working shoulder to shoulder with our clients at the cutting edge of industry and ingenuity,” said Chairman Steve D’Amore. “With that common purpose, we are leveraging both strength and scale by integrating our teams and offices at record speed, working at pace to create a firm that is aligned

Kinaxis Appoints Kristin Russel as Chief Marketing Officer1.6.2026 13:00:00 CEST | Press release

Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain planning and orchestration, today announced the appointment of Kristin Russel as Chief Marketing Officer (CMO). Russel will lead Kinaxis’ global marketing organization, overseeing marketing strategy, corporate and market positioning, digital and brand marketing, communications and go-to-market initiatives. Russel will also take the main stage at Kinexions, where she will discuss practical steps organizations can take to move from decisions to outcomes in an increasingly complex operating environment. A tenured marketing executive and recognized industry leader, Russel brings deep experience scaling technology companies and building high impact brands. She joins Kinaxis from symplr, where she served as Chief Marketing Officer and led the development and execution of the company’s comprehensive marketing strategy across branding, digital and product marketing, public relations, community outreach programs, channel partne

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye